Page last updated: 2024-08-18
framycetin and Peritoneal Neoplasms
framycetin has been researched along with Peritoneal Neoplasms in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, P; Goodly, LJ; Turner, T; Wells, A | 1 |
Other Studies
1 other study(ies) available for framycetin and Peritoneal Neoplasms
| Article | Year |
|---|---|
EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells.
Topics: Animals; Carcinoma; Cell Division; Cell Movement; Enzyme Inhibitors; ErbB Receptors; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neomycin; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplasms, Experimental; Peritoneal Cavity; Peritoneal Neoplasms; Prostate; Prostatic Neoplasms; Signal Transduction; Tumor Cells, Cultured; Type C Phospholipases | 1996 |